SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-027565
Filing Date
2019-08-01
Accepted
2019-07-31 18:06:22
Documents
59
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-10q_20190630.htm   iXBRL 10-Q 1948723
2 EX-31.1 acad-ex311_9.htm EX-31.1 9479
3 EX-31.2 acad-ex312_8.htm EX-31.2 9220
4 EX-32.1 acad-ex321_7.htm EX-32.1 6331
5 EX-32.2 acad-ex322_6.htm EX-32.2 6386
  Complete submission text file 0001564590-19-027565.txt   6517882

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acad-20190630.xsd EX-101.SCH 38180
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20190630_cal.xml EX-101.CAL 56780
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20190630_def.xml EX-101.DEF 93339
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20190630_lab.xml EX-101.LAB 310374
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20190630_pre.xml EX-101.PRE 225923
11 EXTRACTED XBRL INSTANCE DOCUMENT acad-10q_20190630_htm.xml XML 1250769
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 19990139
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences